Acquisition of a 'quiescence programme' by naive T cells is important to provide a stress-free environment and resistance to apoptosis while preserving their responsiveness to activating stimuli. Therefore, the survival and proper function of naive T cells depends on their ability to maintain quiescence. Recently we demonstrated that by preventing chronic unresolved endoplasmic reticulum (ER) stress, Schlafen2 (Slfn2) maintains a stress-free environment to conserve a pool of naive T cells ready to respond to a microbial invasion. These findings strongly suggest an intimate association between quiescence and stress signalling. However, the connection between ER stress conditions and loss of T-cell quiescence is unknown. Here we demonstrate that homeostasis of cholesterol and lipids, is disrupted in T cells and monocytes from Slfn2-mutant, elektra, mice with higher levels of lipid rafts and lipid droplets found in these cells. Moreover, elektra T cells had elevated levels of free cholesterol and cholesteryl ester due to increased de novo synthesis and higher levels of the enzyme HMG-CoA reductase. As cholesterol plays an important role in the transition of T cells from resting to active state, and ER regulates cholesterol and lipid synthesis, we suggest that regulation of cholesterol levels through the prevention of ER stress is an essential component of the mechanism by which Slfn2 regulates quiescence.
Introduction
An immune system must be capable of defending the host while sparing its tissues. To fulfil this task the immune system generates and maintains a vast repertoire of immunologically naive lymphocytes that are maintained in a quiescent state until encountering their specific antigen. This quiescent state is characterized by small size, lack of spontaneous proliferation, and low metabolic rate with a catabolic signature. [1] [2] [3] Acquisition of a 'quiescence programme' is important to provide a stress-free environment and resistance to apoptosis while preserving naive T cells responsive to activating stimuli. 1, [3] [4] [5] [6] Therefore, the survival and proper function of naive T cells depends on their continued quiescence. 1 A growing number of factors, including Forkhead box O1, 7, 8 Kr€ uppel-like factor 2, 9 Transducer of ErbB-2 (TOB), 10 Tuberous Sclerosis Protein (TSC)1, 11,12 TSC2, 13 Forkhead box protein P1 14, 15 and Schlafen2 (Slfn2), 16 are associated with the regulation of quiescence in immune cells. However, lymphocyte quiescence is poorly understood.
The Schlafen genes (Slfn) were first described in mice as a family that is transcribed during thymocyte maturation. 17 Members of the Slfn family are expressed in tissues of the immune system, and their expression levels vary during T-cell and macrophage development as well as in response to infections. 17, 18 Previously, we described a mouse strain bearing the Slfn2-mutated allele, elektra. 16 The elektra mutation causes an isoleucine-to-asparagine substitution of residue 135 of the 278-amino-acid Slfn2 protein leading to its loss of function. In the elektra mutant mouse (Slfn2 eka/eka ), naive newly thymic emigrant (CD44 lo ) cells fail to maintain quiescence and instead acquire a semi-activated phenotype characterized by activation of Jun
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N-terminal kinase and p38 and a higher propensity to enter the cell cycle. Consequently, upon maturation or encountering activation signals, elektra T cells fail to acquire a memory-like phenotype and to engage pro-survival machinery, leading to premature apoptosis. Inflammatory monocytes are affected by the elektra mutation as well, exhibiting similar fragility in the presence of signals that induce their maturation or activation. 16 Following that study, we recently demonstrated that elektra monocytes and T cells exhibit unresolved endoplasmic reticulum (ER) stress, which leads to their impaired proliferation and survival. 19 This study revealed a connection between the loss of quiescence in Slfn2 deficiency and chronic ER stress.
Cholesterol is an essential constituent in mammalian cell membranes and is crucial for cell growth, proliferation, signalling and intracellular trafficking. 20 Cholesterol homeostasis is preserved by two main nuclear receptor systems: sterol regulatory element binding proteins (SREBPs) and liver X receptors (LXRs). SREBP-2 resides in the ER under conditions of sufficient sterol. 21 When cells are depleted of sterols, SREBP-2 is cleaved and transported into the nucleus to activate genes controlling sterol synthesis and uptake, such as 3-hydroxy-3-methylglutaryl-Coenzyme A (HMG-CoA) reductase (HMGCR), HMG-CoA synthase and low-density lipoprotein receptor (LDLR). 21 Alternatively, under conditions of excess cellular cholesterol, the LXR pathway is activated to induce cholesterol efflux through the up-regulation of the lipid transporters, ATP-binding cassette A1 (ABCA1) and ATP-binding cassette transporter G1 (ABCG1). 22 Naive T cells undergo metabolic reprogramming upon their priming by antigen-presenting cells. Rapid up-regulation of lipid-biosynthesis pathways and down-regulation of LXR target genes are key components in this metabolic reprogramming. 23 Cholesterol derivatives (such as oxysterols) or ligand activation of LXR have been shown to inhibit mitogen-driven T-cell expansion by altering cellular sterol content. 23, 24 In addition, loss of LXR or cholesterol transporter ABCG1 expression confers a proliferative advantage to lymphocytes, resulting in enhanced homeostatic and antigen-driven responses. 23, 25, 26 These and other studies provide strong evidence that sterol and lipid levels play a critical role during the transition from a quiescent lymphocyte to an activated lymphocyte. However, the molecular mechanisms that link the lipid/sterol anabolic programme to quiescence disruption remain poorly defined. Moreover, the question of whether there is a functional connection between previously identified T-cell quiescence factors and sterol homeostasis has yet to be addressed.
In the present study, we demonstrate that the loss of function mutation, elektra, in the quiescence factor Slfn2 leads to accumulation of cholesterol due to increased de novo synthesis in T cells and inflammatory monocytes. Our results establish a potential role for the quiescence factor Slfn2 in maintaining quiescence through regulating sterol homeostasis.
Materials and methods

Mice
Slfn2
eka/eka mice were previously generated as described in Berger et al. 16 C57BL/6J (wild-type) mice were from The Jackson Laboratory (Bar Harbor, ME). Mice were maintained and bred under specific pathogen-free conditions in the Hebrew University's animal facilities according to the Institutional Animal Care and Use Committee's regulations. All mice were maintained on the C57BL/6 background and used for experiments between 8 and 12 weeks.
Inflammatory monocytes and T-cell isolation
For monocyte isolation, total bone marrow cells were harvested and inflammatory monocytes were isolated using the EasySep mouse monocyte isolation kit (Stem Cell Technologies, Vancouver, Canada is the difference in the threshold cycle between the gene of interest and the housekeeping gene (mUBC), S is the elektra mouse, and C is the C57BL/6J control mouse. In Fig. 1(b) , the mean value of the C group was returned to 1 in each gene tested.
Flow cytometry
To visualize lipid rafts, splenocytes were labelled with conjugated monoclonal antibody against CD4 and CD8 The following antibodies were used for flow cytometry: anti-CD8a (53-6.7), anti-CD4 (L3T4), anti-CD11b (M1/70) and anti-Ly6C (AL-21). All antibodies were from BioLegend (San Diego, CA).
Cholesterol content in T cells
This procedure was performed as previously described: 26 2Á5 9 10 6 positively isolated total T cells were pelleted by low-spin centrifugation. After several washes with PBS, the cell pellet was extracted with isopropanol containing 5-cholestane as an internal standard. Total and free cholesterol contents were determined by gas-liquid chromatography and normalized to cellular protein, as previously described. 27 Cholesteryl ester was calculated as (total cholesterol -free cholesterol) 9 1Á67. Multiplying by 1Á67 corrects for the average fatty acid mass that is lost during saponification.
T-cell cholesterol and cholesteryl ester biosynthesis rate
Cellular cholesterol biosynthesis was assayed after incubation of 5 9 10 6 cells (purified T cells) for 3 hr at 37°w ith [ 3 H]acetate (3Á3 lCi/ml) in serum-free medium (RPMI-1640) supplemented with 0Á2% BSA. 28 Cellular lipids were extracted with hexane/isopropanol (3 : 2, v/v) and the upper phase was dried under nitrogen. The lipids were then separated by thin-layer chromatography on silica gel plates and developed in hexane/ether/acetic acid Quantitative real-time PCR primers used in this study High-density lipoprotein-mediated cholesterol efflux from T cells Cells (3 9 10 6 ) were incubated with 3 H-labelled cholesterol (2 lCi/ml) in serum-free medium supplemented with 0Á2% BSA for 1 hr at 37°. After washing with PBS, the cells were further incubated with RPMI-1640 in the presence of high-density lipoprotein (HDL) (100 lg HDL protein/ml) or in the absence of HDL for 3 hr at 37°. Cellular and medium 3 H labels were quantified by b-counter (Packard Tri Carb 2100TR, PerkinElmer), and the basal or HDL-mediated cholesterol efflux was calculated as the ratio of 3 H label in the medium/( 3 H label in the medium + 3 H label in the cells). Net HDL-mediated cholesterol efflux data were corrected for the basal level.
Western blot analysis
Purified naive CD4 T cells (5 9 10 6 to 10 9 10 6 ) were lysed in radioimmune precipitation assay (RIPA) buffer; 20 lg protein from each sample was separated by SDS-PAGE, and immunoblotted with goat anti-HMGCR C-18 (Santa Cruz Biotech, Dallas, TX; sc-27578) followed by peroxidase bovine anti-goat IgG (Jackson Laboratory; 805-035-180). Blotting with anti AMPKa antibody (Cell Signalling, Danvers, MA; 2532) followed by peroxidase donkey anti-rabbit IgG (Jackson Laboratory; 711-005-152) were used as a loading control.
Results
Lipid and sterol-related genes are altered in Slfn2 eka/eka monocytes Our previous research revealed the essential role that Slfn2 plays in the defence against multiple pathogens as it maintains quiescence in immune cells. 16 Following this study, we demonstrated a further essential role for Slfn2 in the progression of diseases involving aberrant T-cell development, such as T-cell acute lymphoblastic leukaemia. 29 Moreover, most recently we established for the first time a functional connection between the loss of quiescence in Slfn2 deficiency and chronic, unresolved ER stress. 19 These findings strongly indicate that there is an intimate association between quiescence and stress signalling. Hence, we hypothesize that the development of stress conditions will accompany the loss of cellular quiescence, which will be countered by compensatory responses mediated by Slfn2. This balance may substantially influence decisions that determine the fates of T cells.
To better describe stress signals activated by the loss of function of Slfn2, we compared the transcriptome profiling of Slfn2 eka/eka to wild-type cells. To avoid possible secondary defects, such as activation of apoptotic signalling pathways mediated by the elektra mutation, we analysed monocyte precursors (CD11b + /ly6C hi ) from the bone marrow. These cells are phenotypically normal and viable in elektra mice; however, they undergo rapid cell death upon their maturation or activation. 16 The gene expression profile (Fig. 1a) show that in addition to ER stress related genes (our published data 19 ), Slfn2 eka/eka bone marrow monocytes have altered expression levels of lipid/sterol-related genes in comparison to bone marrow monocytes from wild-type mice.
Among the genes found to be elevated in Slfn2 eka/eka in comparison to wild-type monocytes are: ACAT2, which codes for the ER membrane-bound sterol O-acyltransferase 2, which produces intracellular cholesteryl esters from long-chain fatty acyl CoA and cholesterol;
30 AGPAT9 (1-acylglycerol-3-phosphate O-acyltransferase 9, the gene encoding for GPAT3), which regulates triacylglycerol biosynthesis and cytosolic lipid droplet formation 31, 32 ; meteorin-like (METRNL), which is highly expressed in activated monocytes and during adipogenesis and encodes for a protein that promotes lipid metabolism and inhibits adipose inflammation. 33, 34 Furthermore, our gene profile analysis showed that Slfn2 eka/eka monocytes have highly reduced levels of the genes ALOX15, FABP4 and HPGD, which have regulatory roles in fatty acid and cholesterol metabolism, 35, 36 fatty acid uptake/transport 37 and lipid/ prostaglandin metabolism, 38 respectively. Microarray results were validated by real-time PCR (Fig. 1b) . These findings suggest that the elektra mutation in Slfn2 leads to disruption in both lipid and sterol homeostasis in bone marrow monocytes.
Elevated lipid droplets and lipid rafts in bone marrow monocytes and T cells from Slfn2
eka/eka mice To test whether the elektra mutation in Slfn2 leads to impaired intracellular balance of cholesterol and lipids, we compared general components of lipid and sterol between wild-type and Slfn2 eka/eka monocytes and T cells. Cholesterol is an important component of the membrane's highly ordered ganglioside-rich platform lipid rafts. Therefore, we quantified the membrane lipid raft content in wild-type and Slfn2 eka/eka monocytes (Fig. 2a ) and T cells (Fig. 2b) using fluorescently labelled cholera toxin-B, which binds to the pentasaccharide chain of ganglioside GM1, a raft-associated lipid. 39 We observed a significant increase in the lipid rafts in the plasma membrane of Slfn2 eka/eka monocytes (Fig. 2a) and in both CD4 and CD8 resting T cells (Fig. 2b) . Additionally, we measured lipid droplet levels in wild-type and Slfn2 eka/eka cells. Lipid droplets provide reservoirs of lipids (such as sterols, fatty acids and phospholipids) for membrane synthesis and energy sources. 40 Flow cytometry analysis revealed dramatically increased lipid droplet levels in both Slfn2 eka/eka monocytes (Fig. 2c) and T lymphocytes in comparison with wild-type cells (Fig. 2d ). Our data demonstrate that loss of function mutation in Slfn2 leads to aberrant content of lipids and membrane sterol in T cells.
Elevated cholesterol and cholesteryl ester content in T lymphocytes from Slfn2
eka/eka mice Modulating intracellular levels of cholesterol can alter the membrane structure and lipid droplet content. 20, 21 Therefore, it is possible that the increased content in lipid droplets and lipid rafts observed in Slfn2 eka/eka cells is due to accumulation of intracellular levels of cholesterol. To test this hypothesis we measured cholesterol content using gas-liquid chromatography in resting wild-type and Slfn2 eka/eka T cells isolated from the spleens. Indeed, total (Fig. 3a) , free cholesterol (Fig. 3b ) and cholesteryl ester (Fig. 3c) were all highly elevated in Slfn2 eka/eka T cells. Notably, the observed increased cholesterol levels in Slfn2 eka/eka T cells is robust in comparison to the elevation previously reported in other aberrant cholesterol accumulation phenotypes in T cells. 26 These results demonstrate an excess of cellular cholesterol in Slfn2 eka/eka T cells. Under such conditions the LXR pathway is expected to be activated. Therefore, we compared the expression level of the main LXR target genes in Slfn2 eka/eka versus wild-type T cells. This analysis revealed a slightly increased expression of SREBP1-c in Slfn2 eka/eka T cells with no change in the expression of ABCA1 and ABCG1, which increases cholesterol efflux through the lipid transporters (Fig. 3d) .
These results demonstrate that the elektra mutation in Slfn2 leads to accumulation of cholesterol in T cells with only minimal activation of the compensatory, LXR pathway.
Accumulation of cholesterol in Slfn2
eka/eka T cells is caused by elevated de novo synthesis Next, we aimed to find the cause of the increased cholesterol in elektra T cells. Cellular cholesterol homeostasis is maintained by the balance between uptake, efflux and endogenous de novo synthesis. 41 Therefore, initially, as a proxy for cholesterol uptake we compared the LDL uptake by elektra and wild-type T cells using LDL-FITC followed by flow cytometry analysis. In comparison to wild-type cells, elektra CD4 and CD8 T cells show, respectively, slightly elevated or equal uptake of LDL (Fig. 4a) . Next, excess cholesterol efflux measurement unexpectedly revealed no significant differences between T cells from Slfn2 eka/eka and wild-type mice (Fig. 4b) . Finally we measured the de novo synthesis of free cholesterol, which reflects the activity of the enzyme HMG-CoA and found a fivefold increase in Slfn2 eka/eka T cells (Fig. 4c) . In addition, we observed a 2Á7-fold increase in cholesteryl ester synthesis in elektra cells compared with naive wild-type cells (Fig. 4d) . This de novo synthesis is supported by elevated HMG-CoA reductase protein levels in Slfn2 eka/eka T cells in comparison to wild-type cells (Fig. 4e) . Interestingly, SREBP-2 target genes, including HMG-CoA reductase mRNA, were not elevated in elektra T cells (Fig. 4f) , so excluding SREBP-2 activation as the cause for the elevated cholesterol de novo synthesis.
These results demonstrate that the elektra mutation in Slfn2 leads to disruption of cholesterol homeostasis in T cells, mainly through elevating the de novo synthesis of cholesterol with no influence on cholesterol uptake and efflux.
Discussion
Our results demonstrate that a loss of function mutation in the quiescence factor Slfn2 caused impaired cholesterol homeostasis in T cells as a consequence of induced de novo cholesterol synthesis and elevated protein expression of the enzyme HMGCR.
Although Slfn2 eka/eka T cells had higher de novo cholesterol synthesis levels, no substantial elevation in the efflux or reduction in uptake of cholesterol was observed. In addition, lipid droplets and lipid rafts accumulated in these cells. These results suggest that there is no activation of compensatory mechanisms to oppose the higher de novo synthesis in Slfn2 eka/eka T cells. Therefore, we consider that the impaired cholesterol homeostasis in Slfn2 eka/eka T cells stems from a defect in sensing excess amounts of cholesterol or from activation of a cellular programme that sets the default cholesterol content at higher levels than in wild-type T cells.
T-cell quiescence is an actively enforced cell programme aimed at maintaining a stress-free environment to allow long-term survival while maintaining the ability to enter and progress through the cell cycle upon stimulation. Retaining this programme requires induction of cell cycle arrest and enforcement of low metabolism rate with a catabolic signature, part of which is the inhibition of sterol/ lipid synthesis. Upon activation, T cells reprogramme their metabolism to meet the extraordinary demands of cell division by the induction of pathways involved in cell growth. 42 Among these anabolic pathways is the lipid/sterol biogenesis pathway, which is activated following T-cell receptor stimulation, enabling the activated cells to meet the dramatic requirements for membrane synthesis. Our current findings suggest that inhibition of cholesterol's de novo synthesis anabolic pathway is one of the mechanisms by which Slfn2 maintains quiescence in T cells. A recent study from our group illustrated that Slfn2 eka/eka T cells display chronic ER stress and die as a result of ER stress-induced apoptosis. 19 The connection between ER stress and accumulation of cholesterol is well established. Tabas and colleagues showed that an excess of cellular cholesterol in macrophages induces unfolded protein response (UPR) activation and ER stress-induced apoptosis. 43 Free cholesterol enrichment of the normally cholesterol-poor ER membrane has been shown to inhibit the ER calcium pump, sarcoplasmic-endoplasmic reticulum calcium ATPase-2b (SERCA2b), resulting in depletion of ER calcium stores. This may be a critical event in the induction of UPR and free-cholesterol-induced apoptosis. 44 These studies suggest that the ER stress is a consequence of cholesterol accumulation. However, as ER is the major site for synthesis and sensing of phospholipids and sterols, it is possible that ER stress directly leads to sterol accumulation. Although UPR was initially identified as a mechanism to maintain protein homeostasis and proper folding in the ER, it has also been shown to be involved in the control of lipid/sterol homeostasis. For example, improving the ER protein folding capacity by overexpression of the chaperone glucose-regulated protein 78 (GRP78 or BiP) in the livers of the leptin-deficient, ob/ob mice led to reduced hepatic triglyceride and cholesterol content. 45 Furthermore, the processing enzymes site-1 protease (S1P) and site-2 protease (S2P) that cleave and activate the UPR-induced transcription factor ATF6, are also responsible for the cleavage and activation of the transcription factors SREBP-1c and SREBP-2 that regulate the synthesis of lipid and cholesterol. 46 Finally, the UPRinduced transcription factor, XBP1, was identified as a critical regulator of lipid metabolism in the liver by directly regulating lipogenic genes including Dgat2, Scd1 and Acc2. 47 Selective deletion of XBP1 in the liver caused hypocholesterolaemia and hypotriglyceridaemia, secondary to a decreased production of lipids from the liver. 47 In lymphocytes, as opposed to macrophages, cholesterol accumulation has been shown to provide several advantages. 26, 48 Primarily, isotopomer-enrichment studies showed that activation of lymphocytes results in a rapid increase in new biosynthesis of cholesterol and fatty acids. 49 In addition, pharmacological inhibition of the enzyme HMGCR by statins inhibited anti-CD3-induced T-cell mitogenesis in a dose-dependent manner. 24 Finally, Hedrick and colleagues demonstrated that robust cholesterol accumulation by genetic depletion of the cholesterol transporter, ABCG1, not only did not cause ER stressinduced apoptosis, it actually provided a proliferative advantage for naive T cells. 26 Based on these studies, we believe that the observed cholesterol accumulation in Slfn2 eka/eka T cells is most likely secondary to the chronic (grey) using quantitative RT-PCR (n = 4 mice). Not significant (n.s.) > 0Á05, *P < 0Á05, **P < 0Á01 and ***P < 0Á001 (two-tailed Student's t-test). Error bars are SEM. ER stress. Therefore, our results suggest that similar to hepatocytes, ER stress plays an important role in regulating cholesterol and lipid synthesis in T lymphocytes.
In our previous study we showed that by genetically inhibiting the ER stress response we could partially rescue the 'loss of quiescence phenotype' resulting from the loss- of-function mutation in the quiescence factor Slfn2. In line with the current study's results, we hypothesize that one optional mechanism by which ER stress disrupts quiescence of T cells is the up-regulation of cholesterol and cholesteryl ester synthesis. Recently, it was demonstrated that activated CD8 T cells rapidly re-programme their sterol metabolism towards cholesterol accumulation through the activity of SREBP and LXR to promote cholesterol synthesis and uptake, while inhibiting efflux. 23, 48 Furthermore, disrupting the activity of SREBP signalling in CD8 T cells has been shown to prevent their blasting and attenuated clonal expansion during viral infection. 48 Expression of the cholesterol esterification genes, acyl-CoA cholesterol, acyltransferase (ACAT), in particular ACAT1, is up-regulated in activated CD8 T cells.
50 ACAT1 and ACAT2 reside in the ER and convert free cholesterol to cholesteryl esters to be stored in the lipid droplets. Overall, these studies and others indicate that intracellular cholesterol levels provide a threshold for T-cell activation, a threshold that, if passed, may result in a spontaneous loss of quiescence.
Finally, our study shows that the enzyme HMGCR is upregulated in Slfn2 eka/eka cells. This enzyme catalyses the rate-limiting formation of mevalonate, which is the first committed precursor for cholesterol synthesis. 51 The level of HMGCR is negatively regulated by cholesterol both transcriptionally and post-translationally. 52 In Slfn2 eka/eka cells, we observed elevation in the protein level of HMGCR with no elevation of HMGCR mRNA and other SREBP2 target genes. These results may suggest that the HMGCR is controlled at the protein level by Slfn2. Therefore, it would be interesting to study the molecular mechanism by which Slfn2 deficiency causes this elevation and determine whether there is a direct interaction between Slfn2 and HMGCR. Additionally, it would be interesting to study whether the elektra phenotype can be reverted by inhibiting HMGCR activity by statin treatment. This will allow dissection of the overall contribution of the elevated HMGCR levels and cholesterol biosynthesis to the survival and development of elektra T cells.
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